Anti-VEGF therapy is not a magic bullet for diabetic retinopathy

Eye (Lond). 2020 Apr;34(4):609-610. doi: 10.1038/s41433-019-0652-3. Epub 2019 Oct 28.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use
  • Bevacizumab / therapeutic use
  • Diabetes Mellitus*
  • Diabetic Retinopathy* / drug therapy
  • Humans

Substances

  • Angiogenesis Inhibitors
  • Bevacizumab